Compare RVMD & TSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVMD | TSN |
|---|---|---|
| Founded | 2014 | 1935 |
| Country | United States | United States |
| Employees | 883 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2B | 21.6B |
| IPO Year | N/A | 1994 |
| Metric | RVMD | TSN |
|---|---|---|
| Price | $141.64 | $64.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 10 |
| Target Price | ★ $140.84 | $66.90 |
| AVG Volume (30 Days) | ★ 3.7M | 2.0M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 3.21% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $54,441,000,000.00 |
| Revenue This Year | N/A | $5.74 |
| Revenue Next Year | $533.02 | $1.14 |
| P/E Ratio | ★ N/A | $265.21 |
| Revenue Growth | N/A | ★ 2.12 |
| 52 Week Low | $34.00 | $50.56 |
| 52 Week High | $155.70 | $66.24 |
| Indicator | RVMD | TSN |
|---|---|---|
| Relative Strength Index (RSI) | 63.40 | 52.58 |
| Support Level | $93.39 | $62.32 |
| Resistance Level | $155.70 | $65.59 |
| Average True Range (ATR) | 7.73 | 1.39 |
| MACD | -0.33 | -0.14 |
| Stochastic Oscillator | 51.39 | 49.24 |
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Tyson Foods is a protein-focused food producer, selling raw chicken, beef, pork, and prepared foods. Chicken and beef are its two largest segments, composing about 40% and 30% of sales, respectively. Prepared foods constituted 18% of fiscal 2025 sales and include brands like Tyson, Jimmy Dean, Hillshire Farm, Ball Park, and Sara Lee. However, most of these are in product categories rife with competition where Tyson does not have a massive market share lead. Tyson sells some products overseas, but the international segment accounts for just 4% of total revenue. The company is an active acquirer, with more recent years' purchases focused on international and food-service markets.